Last updated on May 2018

Hepatocellular Carcinoma in HIV-infected Patients

Brief description of study

Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.

Clinical Study Identifier: NCT02785835

Contact Investigators or Research Sites near you

Start Over

Eduardo Martínez

Hospital de Galdakao
Galdakao, Spain
  Connect »

Koldo Aguirrebengoa

Hospital de Cruces
Bilbao, Spain
  Connect »

Sofia Ibarra Ugarte

Hospital de Basurto
Basurto, Spain
  Connect »

Rafael Silvariño

Hospital de San Eloy
Barakaldo, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.